Daniel Crookshank Joins Mylan as VP of investor relations
This article was originally published in Scrip
Mylan(US) has appointed Daniel Crookshank vice-president of investor relations and as a member of the company's senior leadership team. He will be responsible for all investment community communication, and for the development and direction of activities that promote Mylan to the investment community. Mr Crookshank most recently served as vice-president of investor relations for Rockwell Collins.
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.